CENTRAL ADELAIDE LOCAL HEALTH NEWORK INC.;Newcastle Innovation Ltd.
发明人:
Angel Lopez,Paul Foster
申请号：
US14638579
公开号：
US20150232564A1
申请日:
2015.03.04
申请国别(地区):
US
年份:
2015
代理人:
摘要：
A method of reducing IL-4 and/or IL-13 levels in the lung of a mammal with elevated levels thereof, includes the step of administering to the mammal an effective amount of a βc receptor blocker capable of blocking the binding of all three of IL-3, IL-5 and GM-CSF to the βc common chain to thereby reduce the IL-4 and/or IL-13 levels.
